Hjem › Hjernetumorer › Utah
Hjernetumorer kliniske forsøg i Utah
8 studier for Hjernetumorer søger deltagere på steder i Utah.
Byer i Utah
Officiel studietekst (engelsk)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07326566A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04511013Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Primary Children's Hospital, Salt Lake City
RekruttererFase 2
59 Months · Alle køn · Opdateret 15. sep. 2026 · NCT05535166A Phase 1/1b Study of IAM1363 in HER2 Cancers
- START Mountain Region, West Valley City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06253871Stereotactic Radiosurgery Dose Escalation for Brain Metastases
- Huntsman Cancer Institute, Salt Lake City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT02390518Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of Utah, Huntsman Cancer Institute, Salt Lake City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT06810544Guided Meditation During Radiation Therapy for Brain Tumors
- Huntsman Cancer Institute, Salt Lake City
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 20. mar. 2026 · NCT06165653Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
- Huntsman Cancer Institute, Salt Lake City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 3. dec. 2025 · NCT06194929Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.